Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
Clinical Nutrition ESPEN
|
August 24, 2024
Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis
Taha Koray Sahin, Deniz Can Guven
Breast Cancer Research and Treatment
|
January 19, 2024
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis
Deniz Can Guven, Taha Koray Sahin
Cureus
|
September 15, 2022
Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report
Hakan Taban, Deniz Can Guven, Saadettin Kılıçkap
Expert Review of Anticancer Therapy
|
March 13, 2025
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitors
Taha Koray Sahin, Sercan Aksoy, Deniz Can Guven
Cancers
|
January 11, 2024
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
Deniz Can Guven, Taha Koray Sahin, Saadettin Kilickap
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 16, 2022
Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis
Onur Bas, Enes Erul, Deniz Can Guven, et al.
Critical Reviews in Oncology/Hematology
|
June 17, 2025
IGF-1R inhibitors in cancer: A review of available evidence and future outlook
Deniz Can Guven, Jibran Ahmed, Bettzy Stephen, et al.
Cureus
|
July 19, 2021
Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature Review
Ecem Yigit, Deniz Can Guven, Sercan Aksoy, et al.
Future Oncology (London, England)
|
February 27, 2020
Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications
Deniz Can Guven, Burak Yasin Aktas, Cem Simsek, et al.
Biomarkers in Medicine
|
October 16, 2020
Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives
Deniz Can Guven, Taha K Sahin, Omer Dizdar, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
Clinical Nutrition ESPEN
|
August 24, 2024
Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis
Taha Koray Sahin, Deniz Can Guven
Breast Cancer Research and Treatment
|
January 19, 2024
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis
Deniz Can Guven, Taha Koray Sahin
Cureus
|
September 15, 2022
Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report
Hakan Taban, Deniz Can Guven, Saadettin Kılıçkap
Expert Review of Anticancer Therapy
|
March 13, 2025
Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitors
Taha Koray Sahin, Sercan Aksoy, Deniz Can Guven
Cancers
|
January 11, 2024
The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer
Deniz Can Guven, Taha Koray Sahin, Saadettin Kilickap
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
August 16, 2022
Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis
Onur Bas, Enes Erul, Deniz Can Guven, et al.
Critical Reviews in Oncology/Hematology
|
June 17, 2025
IGF-1R inhibitors in cancer: A review of available evidence and future outlook
Deniz Can Guven, Jibran Ahmed, Bettzy Stephen, et al.
Cureus
|
July 19, 2021
Radiation Recall Dermatitis in Patients Treated With Immune Checkpoint Inhibitors: A Case Report and Literature Review
Ecem Yigit, Deniz Can Guven, Sercan Aksoy, et al.
Future Oncology (London, England)
|
February 27, 2020
Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications
Deniz Can Guven, Burak Yasin Aktas, Cem Simsek, et al.
Biomarkers in Medicine
|
October 16, 2020
Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives
Deniz Can Guven, Taha K Sahin, Omer Dizdar, et al.
Page
of 14